CombiMatrix Corporation (Nasdaq: CBMX), a molecular diagnostics company performing DNA-based testing services for developmental disorders and cancer, announced today that ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE